Immunomedics Inc (NASDAQ:IMMU) - Share price - Overview

Stock Report

Immunomedics Inc IMMU

Last Price
$7.50

Day Change
-0.08|-1.06%

As of 24/05/2017
16:17:43 EDT | USD
Minimum 15 Minutes Delay.

Last Close7.58
Day Range7.42 - 7.65
Mkt Cap822.00Mil
52-Wk Range1.95 - 7.70
Yield %-
ISINUS4529071080
Volume1,605,821
P/E-6.64
P/S222.22
P/CF-12.45

Share Price

Financials
201420152016
More ...
Income Statement
Revenue9.04-3.23
Operating Income-35.58--59.01
Net Income-35.43--59.04
Basic EPS-0.42-0.51-0.62
Avg. Diluted Shares Outstanding859395
Balance Sheet
Current Assets44.74103.4952.95
Non Current Assets2.102.294.00
Total Assets46.84105.7856.95
Current Liabilities6.4812.0815.42
Total Liabilities7.49109.69113.77
Total Equity39.35-3.91-56.82
Cash Flow
Operating Cash Flow-30.91-39.00-48.46
Capital Expenditure-0.38-0.92-2.23
Free Cash Flow-31.29-39.92-50.69

In millions, except "Basic EPS". Currency is USD.

Company Profile

Immunomedics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Blend

Fiscal Year Ends

June

Employees

131
Key Stats
More ...
Price/Earning TTM-6.71
Price/Book-6.33
Price/Sales TTM250.17
Rev Growth (3 year avg)-13.31
EPS Growth (3 year avg)-
Operating Margin % TTM-1,825.04
Net Margin % TTM-1,825.93
ROE TTM-
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.